The Road Less Traveled: Ciliary Sulcus Implantation of the Preserflo MicroShunt

Introduction: Herein, we report on the option and clinical advantage of the Preserflo MicroShunt insertion into the posterior chamber ciliary sulcus in a patient with advanced pseudoexfoliation glaucoma at a high risk of corneal decompensation. Case Presentation: We describe a 64-year-old...

Full description

Saved in:
Bibliographic Details
Main Authors: Meishar Meisel, Eran Berkowitz, Avi Schwalb, Beatrice Tiosano
Format: Article
Language:English
Published: Karger Publishers 2025-01-01
Series:Case Reports in Ophthalmology
Online Access:https://karger.com/article/doi/10.1159/000543219
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850133592226660352
author Meishar Meisel
Eran Berkowitz
Avi Schwalb
Beatrice Tiosano
author_facet Meishar Meisel
Eran Berkowitz
Avi Schwalb
Beatrice Tiosano
author_sort Meishar Meisel
collection DOAJ
description Introduction: Herein, we report on the option and clinical advantage of the Preserflo MicroShunt insertion into the posterior chamber ciliary sulcus in a patient with advanced pseudoexfoliation glaucoma at a high risk of corneal decompensation. Case Presentation: We describe a 64-year-old advanced pseudoexfoliation glaucoma patient who despite maximal tolerated medical therapy and two failed glaucoma surgeries, still suffered from uncontrolled intraocular pressure (IOP) of 36 mm Hg in his left eye. The patient underwent the implantation of the Preserflo MicroShunt. The shunt was placed nasally into an area of unscarred conjunctiva, with the anterior part of the shunt inserted into the ciliary sulcus. Postoperatively, the patient’s IOP dropped to 6 mm Hg on the first day and stabilized at 11 mm Hg at the 6-month mark. An elevated, posteriorly located bleb was observed, and the patient no longer required additional topical medications. Endothelial cell (EC) count remained stable with no signs of corneal edema. The patient did not experience any serious postoperative complications. Conclusion: Implantation of the Preserflo MicroShunt into the ciliary sulcus appears to be a viable option for patients at high risk of corneal decompensation, hence, offering effective IOP control while minimizing EC loss. Further studies with larger patient groups are warranted to better evaluate the safety and efficacy of this technique.
format Article
id doaj-art-8dac35c9ef4b4cacbb0545e4d41d8220
institution OA Journals
issn 1663-2699
language English
publishDate 2025-01-01
publisher Karger Publishers
record_format Article
series Case Reports in Ophthalmology
spelling doaj-art-8dac35c9ef4b4cacbb0545e4d41d82202025-08-20T02:31:55ZengKarger PublishersCase Reports in Ophthalmology1663-26992025-01-01161687310.1159/000543219The Road Less Traveled: Ciliary Sulcus Implantation of the Preserflo MicroShuntMeishar Meiselhttps://orcid.org/0009-0007-0444-7175Eran Berkowitzhttps://orcid.org/0000-0001-6817-7513Avi Schwalbhttps://orcid.org/0000-0003-4969-3701Beatrice Tiosanohttps://orcid.org/0000-0002-1379-4861 Introduction: Herein, we report on the option and clinical advantage of the Preserflo MicroShunt insertion into the posterior chamber ciliary sulcus in a patient with advanced pseudoexfoliation glaucoma at a high risk of corneal decompensation. Case Presentation: We describe a 64-year-old advanced pseudoexfoliation glaucoma patient who despite maximal tolerated medical therapy and two failed glaucoma surgeries, still suffered from uncontrolled intraocular pressure (IOP) of 36 mm Hg in his left eye. The patient underwent the implantation of the Preserflo MicroShunt. The shunt was placed nasally into an area of unscarred conjunctiva, with the anterior part of the shunt inserted into the ciliary sulcus. Postoperatively, the patient’s IOP dropped to 6 mm Hg on the first day and stabilized at 11 mm Hg at the 6-month mark. An elevated, posteriorly located bleb was observed, and the patient no longer required additional topical medications. Endothelial cell (EC) count remained stable with no signs of corneal edema. The patient did not experience any serious postoperative complications. Conclusion: Implantation of the Preserflo MicroShunt into the ciliary sulcus appears to be a viable option for patients at high risk of corneal decompensation, hence, offering effective IOP control while minimizing EC loss. Further studies with larger patient groups are warranted to better evaluate the safety and efficacy of this technique. https://karger.com/article/doi/10.1159/000543219
spellingShingle Meishar Meisel
Eran Berkowitz
Avi Schwalb
Beatrice Tiosano
The Road Less Traveled: Ciliary Sulcus Implantation of the Preserflo MicroShunt
Case Reports in Ophthalmology
title The Road Less Traveled: Ciliary Sulcus Implantation of the Preserflo MicroShunt
title_full The Road Less Traveled: Ciliary Sulcus Implantation of the Preserflo MicroShunt
title_fullStr The Road Less Traveled: Ciliary Sulcus Implantation of the Preserflo MicroShunt
title_full_unstemmed The Road Less Traveled: Ciliary Sulcus Implantation of the Preserflo MicroShunt
title_short The Road Less Traveled: Ciliary Sulcus Implantation of the Preserflo MicroShunt
title_sort road less traveled ciliary sulcus implantation of the preserflo microshunt
url https://karger.com/article/doi/10.1159/000543219
work_keys_str_mv AT meisharmeisel theroadlesstraveledciliarysulcusimplantationofthepreserflomicroshunt
AT eranberkowitz theroadlesstraveledciliarysulcusimplantationofthepreserflomicroshunt
AT avischwalb theroadlesstraveledciliarysulcusimplantationofthepreserflomicroshunt
AT beatricetiosano theroadlesstraveledciliarysulcusimplantationofthepreserflomicroshunt
AT meisharmeisel roadlesstraveledciliarysulcusimplantationofthepreserflomicroshunt
AT eranberkowitz roadlesstraveledciliarysulcusimplantationofthepreserflomicroshunt
AT avischwalb roadlesstraveledciliarysulcusimplantationofthepreserflomicroshunt
AT beatricetiosano roadlesstraveledciliarysulcusimplantationofthepreserflomicroshunt